At a glance
ClinicalIndex Comparison RecordN/ACompleted· 75 enrolled
Drug / intervention
Almond-enriched diet - 1.5 oz +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Comparator-controlled Parallel Study to Investigate the Dose Response of an Almond-enriched Diet on Optimizing HDL-C in a Population With Hypercholesterolemia
In Brief
A clinical study evaluating Almond-enriched diet - 1.5 oz, Almond-enriched diet - 2.5 oz, and 1 other intervention for HDL-C and Hypercholesterolemia. Completed, enrolled 75 participants across 1 site.
Detailed Summary
This study will determine the quantity of almonds (1.5 oz or 2.5 oz) consumed as a snack that will provide optimal increases in HDL-C levels.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHDL-C, Hypercholesterolemia
CountriesCanada
CollaboratorsKGK Science Inc.
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartJan 2022
Primary CompletionNov 2023
TodayJul 2026
First PostedJan 3, 2022
Enrollment StartJan 10, 2022
Primary CompletionNov 18, 2023
TodayJul 1, 2026
Enrollment to primary: 1.9 yearsPosted 4.5 years ago
Interventions
Almond-enriched diet - 1.5 ozother
Participants will receive 1.5 oz of almonds consumed as a snack daily for 16 weeks.
Almond-enriched diet - 2.5 ozother
Participants will receive 2.5 oz of almonds consumed as a snack daily for 16 weeks.
Control snackother
Participants will receive a control snack daily for 16 weeks.